239 related articles for article (PubMed ID: 20044218)
1. Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer.
Trombetta M; Julian TB; Valakh V; Greenberg L; Labban G; Khalid MK; Werts ED; Parda D
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1303-8. PubMed ID: 20044218
[TBL] [Abstract][Full Text] [Related]
2. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
[TBL] [Abstract][Full Text] [Related]
5. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
6. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
7. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
8. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
[TBL] [Abstract][Full Text] [Related]
9. Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast.
Croog VJ; Wu AJ; McCormick B; Beal KP
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):88-93. PubMed ID: 18676095
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
12. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial.
Polgár C; Fodor J; Major T; Németh G; Lövey K; Orosz Z; Sulyok Z; Takácsi-Nagy Z; Kásler M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):694-702. PubMed ID: 17531400
[TBL] [Abstract][Full Text] [Related]
13. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
14. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
[TBL] [Abstract][Full Text] [Related]
15. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598
[TBL] [Abstract][Full Text] [Related]
17. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
[TBL] [Abstract][Full Text] [Related]
18. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
19. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
Poortmans PM; Collette L; Horiot JC; Van den Bogaert WF; Fourquet A; Kuten A; Noordijk EM; Hoogenraad W; Mirimanoff RO; Pierart M; Van Limbergen E; Bartelink H;
Radiother Oncol; 2009 Jan; 90(1):80-5. PubMed ID: 18707785
[TBL] [Abstract][Full Text] [Related]
20. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial.
Polgár C; Sulyok Z; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Somogyi A; Kásler M; Németh G
J Surg Oncol; 2002 Jul; 80(3):121-8; discussion 129. PubMed ID: 12115793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
